| Literature DB >> 17967538 |
Maria Cristina Silva Lourenço1, Felipe Rodrigues Vicente, Maria das Graças Muller de Oliveira Henriques, André Luis Peixoto Candéa, Raoni Schroeder Borges Gonçalves, Thais Cristina M Nogueira, Marcelle de Lima Ferreira, Marcus Vinícius Nora de Souza.
Abstract
The present article describes a series of 21 N-(aryl)-2-thiophen-2-ylacetamides, which were synthesized and evaluated for their in vitro antibacterial activity against Mycobacterium tuberculosis, and the activity expressed as the minimum inhibitory concentration (MIC) in mug/mL. The compounds 2, 3, 7, 8, 11, 12, 15, 16, and 20 exhibited activity between 25 and 100 microg/mL and could be a good start point to find new lead compounds in the fight against multidrug resistant tuberculosis.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17967538 DOI: 10.1016/j.bmcl.2007.09.096
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823